Drug Eluting Stent -Sirolimous Drug with Biodegrable polymer on Cobalt Chromium platform with active coating. Size ranging from length 08 mm to 48 mm and width 2.25 mm to 5.0 mm. The quoted stent to be at least DCGI approved and three years efficacy and safety of the stent in terms of Target Vessel Revascularisation (TVR) and In-Situ Thrombosis (IST) should be documented/published in peer reviewed scientific journals. The documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid. Replacement warranty against any manufacturing defect noted on the O.T. table. The original company brochure mentioning the range of sizes (Diameter & Length) should be submitted along with tender. [AI(2026-27), Item Code-No: S-62066, SL no.2010]

Approved Sources Description :Drug Eluting Stent -Sirolimous Drug with Biodegrable polymer on Cobalt Chromium platform with active coating. Size ranging from length 08 mm to 48 mm and width 2.25 mm to 5.0 mm. The quoted stent to be at least DCGI approved and three years efficacy and safety of the stent in terms of Target Vesse l Revascularisation (TVR) and In-Situ Thrombosis (IST) should be documented/published in peer reviewed sc ientific journals. The documents pertaining to the efficacy and safety of the stent should be enclosed for th e brand that is offered in the tender bid. Replacement warranty against any manufacturing defect noted on the O.T. table. The original company brochure mentioning the range of sizes (Diameter & Length) should be submitted along with tender. [AI(2026-27), Item Code-No: S-62066, SL no.2010] ] Consignee MD/BRSH/SEALDAH, ER West Bengal 60.00 Numbers